- BON ยท Nasdaq
- Medicinal Chemicals & Botanical Products
- Shaanxi, F4
- CIK 0001816815
Updated from SEC filings through
Top things to know
Executives
- Yongwei Hu Chief Executive Officer Form 3, April 10, 2026
- Xin Ma Chief Financial Officer Form 3, April 10, 2026
- Yingchun Xue Chief Operating Officer Form 3, April 10, 2026
- Chen Wenjuan Chief Marketing Officer Form 3, April 10, 2026
- Jing Liu Chief Technology Officer Form 3, April 10, 2026
Bon Natural Life Ltd is a U.S. public company in medicinal chemicals & botanical products (SIC 2833), headquartered in Shaanxi, F4. It trades as BON on Nasdaq. Revenue was $18.7M in the fiscal year ending September 30, 2025, -21.7% from the year before. Yongwei Hu is Chief Executive Officer.
Five-year financials
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $18.7M 20-F, 2026-01-23 | $23.8M 20-F, 2026-01-23 | $29.5M 20-F, 2026-01-23 | $29.9M 20-F/A, 2025-04-16 | $25.5M 20-F/A, 2024-10-11 |
| Operating income | -$1.6M 20-F, 2026-01-23 | $1.9M 20-F, 2026-01-23 | $5.9M 20-F, 2026-01-23 | $6.6M 20-F/A, 2025-04-16 | $5.4M 20-F/A, 2024-10-11 |
| SG&A | $4.3M 20-F, 2026-01-23 | $3.3M 20-F, 2026-01-23 | $2.3M 20-F, 2026-01-23 | $2.2M 20-F/A, 2025-04-16 | $1.3M 20-F/A, 2024-10-11 |
| Net income | -$2.0M 20-F, 2026-01-23 | $398K 20-F, 2026-01-23 | $4.6M 20-F, 2026-01-23 | $6.2M 20-F/A, 2025-04-16 | $4.6M 20-F/A, 2024-10-11 |
Annual figures from XBRL in each company's own filings. Click a figure to open the filing. SG&A marked derived is general and administrative plus selling and marketing.
Leadership and board
| Name | Title | Source |
|---|---|---|
| Yongwei Hu | Chief Executive Officer | Form 3, April 10, 2026 |
| Xin Ma | Chief Financial Officer | Form 3, April 10, 2026 |
| Yingchun Xue | Chief Operating Officer | Form 3, April 10, 2026 |
| Chen Wenjuan | Chief Marketing Officer | Form 3, April 10, 2026 |
| Jing Liu | Chief Technology Officer | Form 3, April 10, 2026 |
Shares and governance
| Shares outstanding | 4.0 million (as of September 30, 2024) | 20-F/A, April 16, 2025 |
|---|---|---|
| Reportable segments | 1 (period ending September 30, 2022) | 20-F/A, October 11, 2024 |
| Auditor | Ycm Cpa Inc (Irvine, California) | Latest 10-K |
Recent 8-K events
No 8-K filings on file.
Frequently asked questions about Bon Natural Life Ltd
- What does Bon Natural Life Ltd do?
- Bon Natural Life Ltd is classified by the SEC as Medicinal Chemicals & Botanical Products (SIC 2833). It is based in Shaanxi, F4.
- What is Bon Natural Life Ltd's revenue?
- $18.7M for the fiscal year ending September 30, 2025, from its 20-F filed January 23, 2026.
- Is Bon Natural Life Ltd profitable?
- Bon Natural Life Ltd reported net income of -$2.0M for the fiscal year ending September 30, 2025.
- Who is the CEO of Bon Natural Life Ltd?
- Yongwei Hu, Chief Executive Officer, as named in a 3 filed April 10, 2026.
- Who is the CFO of Bon Natural Life Ltd?
- Xin Ma, Chief Financial Officer, as named in a 3 filed April 10, 2026.
- Where is Bon Natural Life Ltd headquartered?
- Shaanxi, F4.
- What is Bon Natural Life Ltd's stock ticker?
- BON on Nasdaq.
- What industry is Bon Natural Life Ltd in?
- Medicinal Chemicals & Botanical Products, SIC code 2833.
- What is Bon Natural Life Ltd's website?
- bnlus.com.
- Is Bon Natural Life Ltd a public company?
- Yes. Bon Natural Life Ltd files with the SEC under CIK 0001816815 and trades as BON.
- Who audits Bon Natural Life Ltd?
- Ycm Cpa Inc, Irvine, California, as named in its latest annual report (10-K).
- How many shares of Bon Natural Life Ltd are outstanding?
- 4.0 million shares as of September 30, 2024, from its 20-F/A filed April 16, 2025.
- How many business segments does Bon Natural Life Ltd report?
- 1 reportable segment for the period ending September 30, 2022, from its 20-F/A filed October 11, 2024.